MD Neurology, India
*Corresponding Author: Rajib Dutta, MD Neurology, India.
Received: March 25, 2020; Published: April 01, 2020
The outbreak of SARS-COV-2 (severe acute respiratory syndrome coronavirus 2), that began in December 2019, is still spreading worldwide and presents a significant and urgent threat to global health and economy. Patients with COVID-19 are at risk of acute respiratory distress syndrome (ARDS), respiratory failure and death. Patients aged > 60 years with comorbidities, children and health care workers are highly vulnerable to this virus. The tissue receptor for COVID-19 is Angiotensin-converting enzyme 2 (ACE2) and higher levels of ACE2 can protect against ARDS. Scientists all over the world are actively working to explore drugs or antivirals specific to the virus. Several agents has been reported to be effective, however trials are on currently. Here in this review all therapeutic agents against COVID-19 reported in recent times after the outbreak are being discussed.
Keywords: SARS-COV-2; COVID-19; Treatment
Citation: Rajib Dutta. “COVID-19 Treatment-Review of All Published Literatures till Date". Acta Scientific Microbiology 3.4 (2020): 215-219.
Copyright: © 2020 Rajib Dutta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.